Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
Fig.7.Aa-b
Hantel F et al. (2022) |
Xla Wt + rmnd5a MO
NF14-17 (in situ hybridization) |
|
||||||
Fig.6.E-F
Hantel F et al. (2022) |
Xla Wt + rmnd5a MO
NF32 (in situ hybridization) |
|
neural tube defect
microphthalmia |
|||||
Fig.7.Aa'',a1-a9
Hantel F et al. (2022) |
Xla Wt + rmnd5a MO
NF33/34 (in situ hybridization) |
|
||||||
fig.3.A.f,g,j
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
||||||
fig.3.A.i
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
||||||
fig.3.A.n,o
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
||||||
fig.3.A.n,o,q
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
||||||
fig.3.A.q
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
||||||
fig.3.A.u,v
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|
||||||
fig.3.A.x^1
Pfirrmann T et al. (2015) |
Xla Wt + rmnd5a MO
NF35/36-35 and 36 (in situ hybridization) |
|